M P Davis
Affiliation: Cleveland Clinic Foundation
Davis M. Sigma-1 receptors and animal studies centered on pain and analgesia. Expert Opin Drug Discov. 2015;10:885-900 pubmed publisher
Davis M, Gamier P. New Options in Constipation Management. Curr Oncol Rep. 2015;17:55 pubmed publisher
..This review will discuss the evidence-based benefits of these medications and outline an approach to managing constipation. ..
Davis M, Shaiova L, Angst M. When opioids cause pain. J Clin Oncol. 2007;25:4497-8 pubmed
Davis M, Walsh D. Mechanisms of fatigue. J Support Oncol. 2010;8:164-74 pubmed
..This state-of-the-art review discusses these physiologic correlates of fatigue and the mechanisms described in a variety of chronic diseases. ..
Davis M. Fentanyl for breakthrough pain: a systematic review. Expert Rev Neurother. 2011;11:1197-216 pubmed publisher
..OTFC and INFS have been used effectively to reduce acute pain in children who are opioid-naive. Abuse and addiction to OTFC, fentanyl buccal tablets and INFS was low, owing to patient selection. ..
Davis M, Strasser F, Cherny N, Levan N. MASCC/ESMO/EAPC survey of palliative programs. Support Care Cancer. 2015;23:1951-68 pubmed publisher
..This study not only differs in some respects to a previous survey of palliative care programs but also confirms the late referral of patients to palliative care. ..
Davis M, Strasser F, Cherny N. How well is palliative care integrated into cancer care? A MASCC, ESMO, and EAPC Project. Support Care Cancer. 2015;23:2677-85 pubmed publisher
..Financial concerns limit integration and expansion of palliative care services. Designated cancer centers have more extensive palliative care services relative to nondesignated cancer centers and urban hospitals. ..
Davis M, Temel J, Balboni T, Glare P. A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses. Ann Palliat Med. 2015;4:99-121 pubmed publisher
..However, better designed and executed studies are needed to determine the best time to intervene and the best model of care. ..
Davis M, Khawam E, Pozuelo L, Lagman R. Management of symptoms associated with advanced cancer: olanzapine and mirtazapine. A World Health Organization project. Expert Rev Anticancer Ther. 2002;2:365-76 pubmed
..The pharmacokinetics and pharmacodynamics of both agents are unique and explain many of the benefits. More research and clinical experience will be necessary to define their role in the palliation of advanced cancer. ..